Diphtheria

Diphterie

Diphtheria is caused by bacteria found all over the world. The pathogen produces a strong toxin that permanently damages organs like the heart and lungs. A very effective vaccination provides protection from the disease.

Pathogen and transmission

Diphtheria is an infectious disease caused by the bacterium Corynebacterium diphtheriae. There are two types of diphtheria: respiratory (affecting the airways) and cutaneous (affecting the skin). The pathogen mainly affects the upper respiratory tract and produces a poison (diphtheria toxin) that can lead to dangerous complications and long-term damage. Human to human transmission takes place via droplet infection (close physical contact, coughing, sneezing). It is passed from someone who has the condition or is carrying the bacterium but not showing symptoms. More rarely, the infection is passed on from contaminated objects or, in the case of cutaneous diphtheria, direct contact.

Clinical picture

The disease generally begins gradually with a sore throat, fever and difficulty swallowing two to five days after transmission of the diphtheria bacteria. Later, hoarseness, wheezing and lymph node swelling occurs. An angina-like pharyngitis or tonsillitis occurs, typically with a grey-white, sweet-smelling coating that can spread from the roof of the mouth to the larynx and vocal cords (classic croup). This coating bleeds on removal and in some cases closes the airway to such an extent that the patient experiences severe breathing difficulties or even suffocates.

In infants and young children, nasal diphtheria is usually observed with purulent/bloody sneezing, leading to limited breathing through the nose, anxiety and reduced food intake. Rarely, cutaneous and wound diphtheria can occur, mainly in tropical areas.

In addition to these inflammations, the toxin produced by the bacteria can also lead to serious complications such as heart muscle inflammation, kidney and liver damage or paralysis, even weeks later. The mortality rate for throat diphtheria is high (up to 50%), but this can be reduced to 5-10% with careful administration of an antidote. At the same, the diphtheria bacterium is treated with antibiotics. Unvaccinated young children and older people are particularly at risk of a fatal outcome.

Distribution and frequency

Diphtheria is found all over the world, although it has largely vanished from industrialised countries thanks to the introduction of generalised vaccination. In regions and/or countries with lower vaccination coverage, such as Africa, Asia, Latin America and Eastern Europe, however, it does still occur. The most recent case of throat diphtheria in Switzerland was in 1983.

Prevention

An extremely effective vaccination provides protection from the disease. It is recommended for children in a combination vaccination that also prevents tetanus, whooping cough, polio and Haemophilus influenzae b. It should be administered at 2, 4 and 12 months, then at 4 to 7 and 11 to 15 years. Booster shots are recommended at 25, 45 and 65 years (every twenty years) and then every ten years.

You can request further information on the global distribution and on prevention of the disease from your GP or a specialist in travel medicine.

Last modification 27.03.2019

Top of page

Contact

Federal Office of Public Health FOPH
Division Communicable diseases
Schwarzenburgstrasse 157
3003 Berne
Switzerland
Tel. +41 58 463 87 06
E-mail

Print contact

https://www.bag.admin.ch/content/bag/en/home/krankheiten/krankheiten-im-ueberblick/diphtherie.html